Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
92.4M
-
Number of holders
-
1
-
Total 13F shares, excl. options
-
568
-
Shares change
-
-24.7M
-
Total reported value, excl. options
-
$301
-
Value change
-
-$13.3M
-
Number of sells
-
-49
-
Price
-
$0.53
Significant Holders of Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) as of Q3 2025
50 filings reported holding VRCA - Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value as of Q3 2025.
Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) has 1 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 568 shares
of 92.4M outstanding shares and own 0% of the company stock.
Largest 10 shareholders include OSAIC HOLDINGS, INC. (568 shares), Salomon & Ludwin, LLC (0 shares), Y-Intercept (Hong Kong) Ltd (0 shares), NISA INVESTMENT ADVISORS, LLC (0 shares), Legacy Trust (0 shares), WEALTH ENHANCEMENT ADVISORY SERVICES, LLC (0 shares), SteelPeak Wealth, LLC (0 shares), Sovran Advisors, LLC (0 shares), CITIGROUP INC (0 shares), and Miracle Mile Advisors, LLC (0 shares).
This table shows the top 1 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.